Sunitinib malate and Pneumonia aggravated - a phase IV clinical study of FDA data

Summary:

Pneumonia aggravated is reported as a side effect among people who take Sunitinib malate (sunitinib malate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Afinitor, and have Renal cell carcinoma.

The phase IV clinical study analyzes which people have Pneumonia aggravated when taking Sunitinib malate. It is created by eHealthMe based on reports of 9,155 people who have side effects when taking Sunitinib malate from the FDA, and is updated regularly.

What is Sunitinib malate?

Sunitinib malate has active ingredients of sunitinib malate. eHealthMe is studying from 9,160 Sunitinib malate users. Check the latest studies of Sunitinib malate.

What is Pneumonia aggravated?

Pneumonia aggravated is found to be associated with 2,236 drugs and 885 conditions by eHealthMe. Check the latest studies of Pneumonia aggravated.

On Aug, 06, 2026

9,155 people reported to have side effects when taking Sunitinib malate.
Among them, 384 people (4.19%) have Pneumonia aggravated.

Could Sunitinib malate cause Pneumonia aggravated?

Among these 384 people:

How long have people been on Sunitinib malate when they have Pneumonia aggravated? *

Click here to view more results

What is the gender of people who have Pneumonia aggravated when taking Sunitinib malate? *

Click here to view

What is the age of people who have Pneumonia aggravated when taking Sunitinib malate? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Sunitinib malate and have Pneumonia aggravated?

- Check whether Pneumonia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sunitinib malate:

Sunitinib malate (9,160 reports)

Pneumonia aggravated treatments and more:

Pneumonia aggravated (61 reports)

How severe was Pneumonia aggravated and when was it recovered:

Pneumonia aggravated in Sunitinib malate

Expand to all the drugs that have ingredients of sunitinib malate:

Pneumonia aggravated and drugs with ingredients of sunitinib malate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sunitinib malate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pneumonia aggravated:

Pneumonia aggravated (2,236 drugs)

Browse all the conditions that are associated with Pneumonia aggravated:

Pneumonia aggravated (885 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sunitinib malate (the active ingredients of Sunitinib malate) and Sunitinib malate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.